COMPANY / RESEARCH
Research & Insights
Research advances the methods behind event detection and outcome prediction.
We study how public records reveal events and how institutions use the resulting intelligence.
FEATUREDOriginal Intelligence
What stays valuable when AI can deliver anything. Delivery is becoming a commodity — origination is becoming the whole business.
LATEST
RESEARCH22 JulWhen companies promise a clinical trial result, more than half miss the dateA study of 681 trials on how often result dates slip, and in which direction.ANNOUNCEMENT16 JulAppliedXL partners with Kalshi on verifiable resolution infrastructurePress release · 4 minINTERACTIVE15 JulFrom public record to market resolutionHow one prediction market gets resolved, walked through a drug-trial example.INTERACTIVE6 JunSix clinical trial case studies with full explainabilitySix trials tracked from first filing to outcome, with every probability shift explained.RESEARCH11 MayFive drugs with clinical evidence and no commercial championAppliedXL’s response to the FDA drug repurposing initiative.RESEARCH9 MayClinical trial data as alpha: a biotech quant trading model107 out-of-sample trades, +204% return, 1.32 Sharpe — built on point-in-time intelligence.BENCHMARK9 AprVertical AI vs. general AI on biopharma agentic researchAppliedXL’s floor beats Claude, ChatGPT, and Perplexity’s ceiling across 20 structured queries.
REPORTS
RESEARCH REPORTBiopharma’s Public ProbabilityPrediction markets in drug development.
THESISOriginal IntelligenceWhat stays valuable when AI can deliver anything.
THESISWho Will Monetize Truth?Truth as infrastructure at algorithmic scale.
BOOKThe Science of FirstCatching early signals before they become news.PREVIOUS UPDATES
2026 · 202415 Apr 2026AppliedXL achieves state-of-the-art clinical trial prediction with domain-specific agentic AI07 Dec 2024Seeing risk before it becomes news07 Dec 2024Systematic trading strategies in biotech: early risk signals for alpha generation07 Dec 2024Spillover risk and readthrough alpha: a quantitative analysis07 Dec 2024AppliedXL partners with Bloomberg to integrate real-time biotech intelligence07 Dec 2024AppliedXL and Bain introduce a new operating discipline for pharma06 Dec 2024The hidden signals that decide drug success or failure